Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment.
Pieter Jelle
PJ
Visser
Henrike
H
Wolf
Giovanni
G
Frisoni
Hermann-Josef
HJ
Gertz
D000544:Alzheimer Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D015415:Biomarkers / Q000134:cerebrospinal fluid; D060825:Cognitive Dysfunction / Q000150:complications / Q000175:diagnosis*; D030881:Disclosure / Q000941:ethics / Q000639:trends; D006801:Humans; D010446:Peptide Fragments / Q000134:cerebrospinal fluid; D049268:Positron-Emission Tomography
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42)